Literature DB >> 15451776

Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens.

Linda Cleary1, James Slattery, Sotiria Bexis, James R Docherty.   

Abstract

We have previously demonstrated that contractions of rat vas deferens to exogenous noradrenaline involve predominantly alpha(1A)-adrenoceptors, but that contractions to endogenous noradrenaline involve predominantly alpha(1D)-adrenoceptors. In this study, we have examined the effects of sympathectomy on the subtypes of alpha(1)-adrenoceptor in rat vas deferens in radioligand binding and functional studies. In vehicle-treated tissues, antagonist displacement of [(3)H]prazosin binding to alpha(1)-adrenoceptors was consistent with a single population of alpha(1)-adrenoceptors. Binding affinities for a range of alpha(1)-adrenoceptor antagonists were expressed as pK(i) values and correlated with known affinities for alpha(1)-adrenoceptor subtypes. The correlation was significant only with alpha(1A)-adrenoceptors. In tissues from rats sympathectomised with 6-hydroxy-dopamine (2 x 100 mg kg(-1) i.p.), binding affinity for the alpha(1D)-adrenoceptor antagonist BMY 7378 fitted best with a two-site model. In functional studies, the potency of noradrenaline at producing total (phasic plus tonic) but not tonic contractions was increased in tissues from sympathectomised rats. Results obtained from sympathectomised rats suggest that phasic contractions are mainly alpha(1D)-adrenoceptor mediated, whereas tonic contractions are mainly alpha(1A)-adrenoceptor mediated, based on the effects of BMY 7378 and the alpha(1A)-adrenoceptor antagonist RS 100329. It is concluded that the predominant alpha(1)-adrenoceptor in vehicle-treated rat vas deferens is the alpha(1A)-adrenoceptor, both in terms of ligand binding and contractions to exogenous agonists. The alpha(1D)-adrenoceptor is only detectable by ligand binding following chemical sympathectomy, but is involved in noradrenaline-evoked contractions, particularly phasic contractions, of rat vas deferens. British Journal of Pharmacology (2004).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451776      PMCID: PMC1575931          DOI: 10.1038/sj.bjp.0705987

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Functional characterisation of alpha(1)-adrenoceptors in denervated rat vas deferens.

Authors:  Marcelo Campos; Paola de Lucena Morais; André S Pupo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-05       Impact factor: 3.000

2.  Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle.

Authors:  C Han; P W Abel; K P Minneman
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

3.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

4.  Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.

Authors:  A L Morrow; I Creese
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

5.  Effect of postganglionic denervation and pretreatment with reserpine on alpha-adrenoceptors of the guinea-pig vas deferens.

Authors:  F F Cowan; S K Wong; D P Westfall; W W Fleming
Journal:  Pharmacology       Date:  1985       Impact factor: 2.547

6.  [3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species.

Authors:  C B Neylon; R J Summers
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

7.  [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha 2-adrenoceptors.

Authors:  Y D Cheung; D B Barnett; S R Nahorski
Journal:  Eur J Pharmacol       Date:  1982-10-15       Impact factor: 4.432

8.  A role for protein kinase C in the supersensitivity of the rat vas deferens following chronic surgical denervation.

Authors:  S Thomas Abraham; Mitchell Robinson; Peter J Rice
Journal:  Pharmacology       Date:  2003-01       Impact factor: 2.547

9.  Reserpine and sympathetic denervation cause an increase of postsynaptic alpha 2-adrenoceptors.

Authors:  Y Watanabe; R T Lai; H Maeda; H Yoshida
Journal:  Eur J Pharmacol       Date:  1982-05-07       Impact factor: 4.432

10.  Reserpine-induced postjunctional supersensitivity in rat vas deferens and caudal artery without changes in alpha adrenergic receptors.

Authors:  A Nasseri; J F Barakeh; P W Abel; K P Minneman
Journal:  J Pharmacol Exp Ther       Date:  1985-08       Impact factor: 4.030

View more
  7 in total

1.  alpha1-Adrenoceptors in proximal segments of tail arteries from control and reserpinised rats.

Authors:  Susana Y Kamikihara; André Mueller; Vanessa Lima; Juliana Akinaga; Fernanda D Nojimoto; Anthony Castilho; José Buratini; André S Pupo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-04       Impact factor: 3.000

2.  Alpha1-adrenoceptors are required for normal male sexual function.

Authors:  A Sanbe; Y Tanaka; Y Fujiwara; H Tsumura; J Yamauchi; S Cotecchia; K Koike; G Tsujimoto; A Tanoue
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

Review 3.  Subtypes of functional alpha1-adrenoceptor.

Authors:  James R Docherty
Journal:  Cell Mol Life Sci       Date:  2009-10-28       Impact factor: 9.261

Review 4.  Updates in the function and regulation of α1 -adrenoceptors.

Authors:  Juliana Akinaga; J Adolfo García-Sáinz; André S Pupo
Journal:  Br J Pharmacol       Date:  2019-04-01       Impact factor: 8.739

5.  Role of alpha1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse.

Authors:  S Bexis; J R Docherty
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

6.  Effect of renal sympathetic nerve on adrenergically and angiotensin II-induced renal vasoconstriction in normal Wistar-Kyoto rats.

Authors:  Mohammed H Abdulla; Munavvar A Sattar; Nor A Abdullah; Abdul Hye Khan; Kolla R L Anand Swarup; Hassaan A Rathore; Raisa N Kazi; Fathihah Basri; Edward J Johns
Journal:  Ups J Med Sci       Date:  2010-11-04       Impact factor: 2.384

7.  Physiological and pharmacological aspects of the vas deferens-an update.

Authors:  David S Koslov; Karl-Erik Andersson
Journal:  Front Pharmacol       Date:  2013-08-22       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.